{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:19:31Z","timestamp":1782951571830,"version":"3.54.5"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,7,2]],"date-time":"2019-07-02T00:00:00Z","timestamp":1562025600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,7,2]],"date-time":"2019-07-02T00:00:00Z","timestamp":1562025600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"crossref","award":["2011\/12700-1"],"award-info":[{"award-number":["2011\/12700-1"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100005640","name":"Faculdade de Medicina da Universidade de S\u00e3o Paulo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005640","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Rheumatol"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s42358-019-0071-y","type":"journal-article","created":{"date-parts":[[2019,7,2]],"date-time":"2019-07-02T11:03:56Z","timestamp":1562065436000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Frequency and clinical relevance of anti-Mi-2 autoantibody in adult Brazilian patients with dermatomyositis"],"prefix":"10.1186","volume":"59","author":[{"given":"Maria Isabel Cardoso","family":"dos Passos Carvalho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel Katsuyuki","family":"Shinjo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,7,2]]},"reference":[{"key":"71_CR1","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1056\/NEJM197502202920807","volume":"292","author":"A Bohan","year":"1975","unstructured":"Bohan A, Peter JB. Polymyositis and dermatomyositis (second of two parts). N Engl J Med. 1975;292:403\u20137.","journal-title":"N Engl J Med"},{"key":"71_CR2","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1056\/NEJMra1402225","volume":"372","author":"MC Dalakas","year":"2015","unstructured":"Dalakas MC. Inflammatory muscle diseases. N Engl J Med. 2015;372:1734\u201347.","journal-title":"N Engl J Med"},{"key":"71_CR3","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1111\/j.1365-2990.2010.01153.x","volume":"37","author":"MC Dalakas","year":"2011","unstructured":"Dalakas MC. Review: an update on inflammatory and autoimmune myopathies. Neuropathol Appl Neurobiol. 2011;37:226\u201342.","journal-title":"Neuropathol Appl Neurobiol"},{"key":"71_CR4","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.clindermatol.2006.07.001","volume":"24","author":"JP Callen","year":"2006","unstructured":"Callen JP, Wortmann RL. Dermatomyositis. Clin Dermatol. 2006;24:363\u201373.","journal-title":"Clin Dermatol"},{"key":"71_CR5","first-page":"1565","volume":"64","author":"RA Koler","year":"2001","unstructured":"Koler RA, Montemarano A. Dermatomyositis. Am Fam Physician. 2001;64:1565\u201372.","journal-title":"Am Fam Physician"},{"key":"71_CR6","first-page":"264","volume":"37","author":"FH Souza","year":"2012","unstructured":"Souza FH, Barros TB, Levy-Neto M, Shinjo SK. Adult dermatomyositis: experience of a Brazilian tertiary care center. Rev Bras Reumatol. 2012;37:264\u20137.","journal-title":"Rev Bras Reumatol"},{"key":"71_CR7","doi-asserted-by":"publisher","first-page":"909","DOI":"10.6061\/clinics\/2013(07)04","volume":"68","author":"MG Cruellas","year":"2013","unstructured":"Cruellas MG, Viana V dos S, Levy-Neto M, Shinjo SK. Myositis-specific and myositis-associated autoantibody profiles and their clinical associations in a large series of patients with polymyositis and dermatomyositis. Clinics. 2013;68:909\u201314.","journal-title":"Clinics"},{"key":"71_CR8","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1002\/art.1780280711","volume":"28","author":"IN Targoff","year":"1985","unstructured":"Targoff IN, Reichlin M. The association between Mi-2 antibodies and dermatomyositis. Arthritis Rheum. 1985;28:796\u2013803.","journal-title":"Arthritis Rheum"},{"key":"71_CR9","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1097\/00005792-199111000-00002","volume":"70","author":"LA Love","year":"1991","unstructured":"Love LA, Leff RL, Fraser DD, Targoff IN, Dalakas M, Plotz PH, et al. A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups. Medicine. 1991;70:360\u201374.","journal-title":"Medicine"},{"key":"71_CR10","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.jdermsci.2005.09.004","volume":"40","author":"K Komura","year":"2005","unstructured":"Komura K, Fujimoto M, Matsushita T, Kaji K, Kondo M, Hirano T, et al. Prevalence and clinical characteristics of anti-Mi-2 antibodies in Japanese patient with dermatomyositis. J Dermatol Sci. 2005;40:215\u20137.","journal-title":"J Dermatol Sci"},{"key":"71_CR11","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1080\/08916930600622645","volume":"39","author":"A Ghirardello","year":"2006","unstructured":"Ghirardello A, Zampieri S, Tarricone E, Iaccarino L, Bendo R, Briani C, et al. Clinical implications of autoantibody screening in patients with autoimmune myositis. Autoimmunity. 2006;39:217\u201321.","journal-title":"Autoimmunity"},{"key":"71_CR12","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1111\/j.1346-8138.2011.01262.x","volume":"38","author":"N Ikeda","year":"2011","unstructured":"Ikeda N, Takahashi K, Yamaguchi Y, Inasaka M, Kuwana M, Ikezawa Z. Analysis of dermatomyositis-specific autoantibodies and clinical characteristics in Japanese patients. J Dermatol. 2011;38:973\u20139.","journal-title":"J Dermatol"},{"key":"71_CR13","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1001\/archdermatol.2011.52","volume":"147","author":"Y Hamaguchi","year":"2011","unstructured":"Hamaguchi Y, Kuwana M, Hoshino K, Hasegawa M, Kaji K, Matsushita T, et al. Clinical correlations with dermatomyositis-specific autoantibodies in adult Japanese patients with dermatomyositis: a multicenter cross-sectional study. Arch Dermatol. 2011;147:391\u20138.","journal-title":"Arch Dermatol"},{"key":"71_CR14","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1093\/rheumatology\/kes073","volume":"51","author":"Y Muro","year":"2012","unstructured":"Muro Y, Ishikawa A, Sugiura K, Akiyama M. Clinical features of anti-TIF1-\u03b1 antibody-positive dermatomyositis patients are closely associated with coexistent dermatomyositis-specific autoantibodies and anti-TIF1-\u03b3 or anti-Mi-2 autoantibodies. Rheumatology. 2012;51:1508\u201313.","journal-title":"Rheumatology"},{"key":"71_CR15","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s13317-014-0060-4","volume":"5","author":"A Ghirardello","year":"2014","unstructured":"Ghirardello A, Zampieri S, Iaccarino L, Tarricone E, Bendo R, Gambari PF, et al. Myositis autoantibodies and clinical phenotypes. Autoimmun Highlights. 2014;5:69\u201375.","journal-title":"Autoimmun Highlights"},{"key":"71_CR16","doi-asserted-by":"publisher","first-page":"R48","DOI":"10.1186\/ar4207","volume":"15","author":"MH Petri","year":"2013","unstructured":"Petri MH, Satoh M, Martin-Marquez BT, Vargas-Ram\u00edrez R, Jara LJ, Saavedra MA, et al. Implications in the difference of anti-Mi-2 and -p155\/140 autoantibody prevalence in two dermatomyositis cohorts from Mexico City and Guadalajara. Arthritis Res Ther. 2013;15:R48.","journal-title":"Arthritis Res Ther"},{"key":"71_CR17","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1080\/08916930400022681","volume":"38","author":"A Ghirardello","year":"2005","unstructured":"Ghirardello A, Zampieri S, Iaccarino L, Tarricone E, Bendo R, Gambari PF, et al. Anti-Mi-2 antibodies. Autoimmunity. 2005;38:79\u201383.","journal-title":"Autoimmunity"},{"key":"71_CR18","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.jbspin.2009.08.008","volume":"77","author":"A V\u00e1ncsa","year":"2010","unstructured":"V\u00e1ncsa A, Gergely L, Ponyi A, Lakos G, N\u00e9meth J, Szodoray P, et al. Myositis-specific and myositis-associated antibodies in overlap myositis in comparison to primary dermatopolymyositis: relevance for clinical classification: retrospective study of 169 patients. Joint Bone Spine. 2010;77:125\u201330.","journal-title":"Joint Bone Spine"},{"key":"71_CR19","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1002\/art.40320","volume":"69","author":"IE Lundberg","year":"2017","unstructured":"Lundberg IE, Tj\u00e4rnlund A, Bottai M, Werth VP, Pilkington C, de Visser M, International Myositis Classification Criteria Project Consortium, the Euromyositis Register, and the Juvenile Dermatomyositis Cohort Biomarker Study and Repository (UK and Ireland), et al. 2017 European league against rheumatism\/American college of rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups. Arthritis Rheumatol. 2017;69:2271\u201382.","journal-title":"Arthritis Rheumatol"},{"key":"71_CR20","volume-title":"Aids to the examination of the peripheral nervous system, memorandum no. 45","author":"Medical Research Council","year":"1981","unstructured":"Medical Research Council. Aids to the examination of the peripheral nervous system, memorandum no. 45. London: Her Majesty\u2019s Stationery Office; 1981."},{"key":"71_CR21","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1590\/abd1806-4841.20186803","volume":"93","author":"IBP Borges","year":"2018","unstructured":"Borges IBP, Silva MG, Shinjo SK. Prevalence and reactivity of anti-melanoma differentiation associated gene-5 (anti-MDA-5) autoantibody in Brazilian patients with dermatomyositis. An Bras Dermatol. 2018;93:517\u201323.","journal-title":"An Bras Dermatol"},{"key":"71_CR22","doi-asserted-by":"publisher","first-page":"3784","DOI":"10.1002\/art.24977","volume":"60","author":"AL Mammen","year":"2009","unstructured":"Mammen AL, Casciola-Rosen LA, Hall JC, Christopher-Stine L, Corse AM, Rosen A. Expression of the dermatomyositis autoantigen Mi-2 in regenerating muscle. Arthritis Rheum. 2009;60:3784\u201393.","journal-title":"Arthritis Rheum"}],"container-title":["Advances in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s42358-019-0071-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s42358-019-0071-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s42358-019-0071-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:11:52Z","timestamp":1593562312000},"score":1,"resource":{"primary":{"URL":"https:\/\/advancesinrheumatology.biomedcentral.com\/articles\/10.1186\/s42358-019-0071-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,2]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["71"],"URL":"https:\/\/doi.org\/10.1186\/s42358-019-0071-y","relation":{},"ISSN":["2523-3106"],"issn-type":[{"value":"2523-3106","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,2]]},"assertion":[{"value":"17 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the local Ethics Committee (HCFMUSP, CAPPesq, number 0114\/11) and all participants signed the informed consent form.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"27"}}